ImmunityBio Inc. Securities Litigation Settlement
Last verified July 13, 2026Source: claimdepotHow ClaimWatch verifies cases
This settlement is closed to new claims — the deadline was July 7, 2025. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Lead Plaintiff alleges that ImmunityBio, Inc. and its executives made false or misleading statements regarding the company's securities during the class period. The defendants have agreed to settle the litigation for $10,500,000 in cash without admitting wrongdoing.
Do you qualify?
Anyone who purchased or acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between March 10, 2021, and May 10, 2023, inclusive.
How to file
Submit a Proof of Claim and Release Form to the settlement claims administrator by July 7, 2025. The form must include documentation proving your purchase of ImmunityBio securities during the class period.
Common questions
- How much does the ImmunityBio Inc. Securities Litigation Settlement pay?
- The total settlement fund is $10.5M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
- What is the claim deadline for the ImmunityBio Inc. Securities Litigation Settlement?
- This settlement is closed to new claims — the deadline was July 7, 2025. Once a claim deadline passes you generally forfeit your share, even if you qualified.
- Do I need proof of purchase for the ImmunityBio Inc. Securities Litigation Settlement?
- Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.
- Is the ImmunityBio Inc. Securities Litigation Settlement notice real, or a scam?
- Claims are filed at immunitybiosecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- When will payments from the ImmunityBio Inc. Securities Litigation Settlement be sent?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for June 13, 2025; no payments can be issued before a settlement receives final approval.
Who's involved
Plaintiffs
- Zachary Salzman
Defendants
- Patrick Soon-Shiong
- David C. Sachs
- Richard Adcock
- ImmunityBio, Inc.
Counsel for plaintiffs
Parties and counsel from the public court docket. Listing an attorney here isn't an endorsement, and ClaimWatch isn't affiliated with any of them.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Eagle Pharma Securities Litigation Settlement
Eagle Pharmaceuticals, Inc. is the subject of a securities litigation class action. Shareholders who purchased the company's publicly traded common stock between August 9, 2022 and October 1, 2024 allege claims covered by this settlement, which the defendant has agreed to settle.
…moreHut 8 Corp. Securities Class Action Settlement
Hut 8 Corp. and individual defendants are accused of alleged securities violations. The company and defendants have agreed to settle claims from investors who purchased securities during the class period without admitting wrongdoing.
Kornit Digital Ltd. Securities Litigation Settlement
Kornit Digital Ltd. and its executives are accused of securities fraud in this class action lawsuit. The defendants have denied all claims and admit no wrongdoing, but have agreed to settle the case for $19.5 million to eliminate the burden and expense of continued litigation.
…more